WO2005110394A1 - 糖尿病治療薬 - Google Patents
糖尿病治療薬 Download PDFInfo
- Publication number
- WO2005110394A1 WO2005110394A1 PCT/JP2005/009126 JP2005009126W WO2005110394A1 WO 2005110394 A1 WO2005110394 A1 WO 2005110394A1 JP 2005009126 W JP2005009126 W JP 2005009126W WO 2005110394 A1 WO2005110394 A1 WO 2005110394A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diabetes
- insulin
- acid
- aspartic acid
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006513628A JPWO2005110394A1 (ja) | 2004-05-19 | 2005-05-19 | 糖尿病治療薬 |
EP05741366A EP1752146A4 (en) | 2004-05-19 | 2005-05-19 | THERAPEUTIC AGENT AGAINST DIABETES |
US11/561,518 US20070071794A1 (en) | 2004-05-19 | 2006-11-20 | Drugs for treating diabetes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004149320 | 2004-05-19 | ||
JP2004-149320 | 2004-05-19 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/561,518 Continuation US20070071794A1 (en) | 2004-05-19 | 2006-11-20 | Drugs for treating diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005110394A1 true WO2005110394A1 (ja) | 2005-11-24 |
Family
ID=35393978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/009126 WO2005110394A1 (ja) | 2004-05-19 | 2005-05-19 | 糖尿病治療薬 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20070071794A1 (ja) |
EP (1) | EP1752146A4 (ja) |
JP (1) | JPWO2005110394A1 (ja) |
WO (1) | WO2005110394A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006061992A1 (ja) * | 2004-12-10 | 2006-06-15 | Ajinomoto Co., Inc. | 肝疾患予防・治療用組成物 |
WO2007060924A1 (ja) * | 2005-11-22 | 2007-05-31 | Ajinomoto Co., Inc. | 膵β細胞保護剤 |
WO2007105730A1 (ja) * | 2006-03-13 | 2007-09-20 | Kyowa Hakko Kogyo Co., Ltd. | インスリン抵抗性改善剤 |
WO2007142297A1 (ja) * | 2006-06-09 | 2007-12-13 | Ajinomoto Co., Inc. | 肝疾患予防・治療用組成物 |
JP2010513250A (ja) * | 2006-12-15 | 2010-04-30 | ティーマ ファウンデーション | 組成物およびその使用 |
US9603847B2 (en) | 2006-12-15 | 2017-03-28 | Tima Foundation | Compositions and uses thereof |
US11224582B2 (en) | 2017-04-25 | 2022-01-18 | Almeda Labs Llc | Amino acid formulations for pancreatic viability |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014201411A1 (en) * | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58208218A (ja) * | 1982-05-29 | 1983-12-03 | Snow Brand Milk Prod Co Ltd | 糖尿病治療剤 |
JPS601121A (ja) * | 1983-06-16 | 1985-01-07 | Terumo Corp | 糖配合アミノ酸輸液 |
JPS60255722A (ja) * | 1984-05-30 | 1985-12-17 | Otsuka Pharmaceut Factory Inc | 糖尿病用アミノ酸輸液 |
JPS61501561A (ja) * | 1984-03-01 | 1986-07-31 | ア−ク,バ−ノン | 脊椎動物における低血糖症を治療する方法 |
JPS61501569A (ja) * | 1984-03-01 | 1986-07-31 | ア−ク,バ−ノン | 脊椎動物及びその他の生物において血糖水準を低下させる方法 |
JPH05344863A (ja) * | 1992-06-16 | 1993-12-27 | Meiji Milk Prod Co Ltd | 糖尿病に有効な組成物 |
JPH07118166A (ja) * | 1993-10-19 | 1995-05-09 | Dot:Kk | インシュリン組成物 |
JPH07252145A (ja) * | 1993-10-28 | 1995-10-03 | Clintec Nutrition Co | アミノ酸をベースとする成分 |
JPH09104624A (ja) * | 1995-10-09 | 1997-04-22 | Hokuren Federation Of Agricult Coop:The | α−グルコシダーゼ阻害剤、それを含む糖を主体とする組成物、甘味料、食品及び飼料 |
JPH10500696A (ja) * | 1994-05-26 | 1998-01-20 | ノボ ノルディスク アクティーゼルスカブ | グルカゴンを含んでなる医薬製剤 |
JP2001114681A (ja) * | 1999-10-18 | 2001-04-24 | Ajinomoto Co Inc | ケトーシス改善剤 |
WO2002049636A1 (en) * | 2000-12-19 | 2002-06-27 | Rajagopal Thiruvengadam | An antidiabetic composition of amino acids |
JP2003171271A (ja) * | 2001-09-26 | 2003-06-17 | Ajinomoto Co Inc | 耐糖能異常用薬剤 |
JP2005132831A (ja) * | 2003-10-06 | 2005-05-26 | Ajinomoto Co Inc | 末梢静脈投与用輸液 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000441A1 (en) * | 1991-06-24 | 1993-01-07 | Pacific Biomedical Research, Inc. | Hormone-secreting cells maintained in long-term culture |
WO1994010858A1 (en) * | 1992-11-10 | 1994-05-26 | Otsuka Pharmaceutical Co., Ltd. | Feeding composition |
JP2002154986A (ja) * | 2000-09-11 | 2002-05-28 | Takeda Chem Ind Ltd | インスリン分泌調節剤 |
AR036237A1 (es) * | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
JPWO2004083179A1 (ja) * | 2003-03-19 | 2006-06-22 | 協和醗酵工業株式会社 | 糖尿病治療剤 |
-
2005
- 2005-05-19 EP EP05741366A patent/EP1752146A4/en not_active Withdrawn
- 2005-05-19 WO PCT/JP2005/009126 patent/WO2005110394A1/ja active Application Filing
- 2005-05-19 JP JP2006513628A patent/JPWO2005110394A1/ja active Pending
-
2006
- 2006-11-20 US US11/561,518 patent/US20070071794A1/en not_active Abandoned
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58208218A (ja) * | 1982-05-29 | 1983-12-03 | Snow Brand Milk Prod Co Ltd | 糖尿病治療剤 |
JPS601121A (ja) * | 1983-06-16 | 1985-01-07 | Terumo Corp | 糖配合アミノ酸輸液 |
JPS61501561A (ja) * | 1984-03-01 | 1986-07-31 | ア−ク,バ−ノン | 脊椎動物における低血糖症を治療する方法 |
JPS61501569A (ja) * | 1984-03-01 | 1986-07-31 | ア−ク,バ−ノン | 脊椎動物及びその他の生物において血糖水準を低下させる方法 |
JPS60255722A (ja) * | 1984-05-30 | 1985-12-17 | Otsuka Pharmaceut Factory Inc | 糖尿病用アミノ酸輸液 |
JPH05344863A (ja) * | 1992-06-16 | 1993-12-27 | Meiji Milk Prod Co Ltd | 糖尿病に有効な組成物 |
JPH07118166A (ja) * | 1993-10-19 | 1995-05-09 | Dot:Kk | インシュリン組成物 |
JPH07252145A (ja) * | 1993-10-28 | 1995-10-03 | Clintec Nutrition Co | アミノ酸をベースとする成分 |
JPH10500696A (ja) * | 1994-05-26 | 1998-01-20 | ノボ ノルディスク アクティーゼルスカブ | グルカゴンを含んでなる医薬製剤 |
JPH09104624A (ja) * | 1995-10-09 | 1997-04-22 | Hokuren Federation Of Agricult Coop:The | α−グルコシダーゼ阻害剤、それを含む糖を主体とする組成物、甘味料、食品及び飼料 |
JP2001114681A (ja) * | 1999-10-18 | 2001-04-24 | Ajinomoto Co Inc | ケトーシス改善剤 |
WO2002049636A1 (en) * | 2000-12-19 | 2002-06-27 | Rajagopal Thiruvengadam | An antidiabetic composition of amino acids |
JP2003171271A (ja) * | 2001-09-26 | 2003-06-17 | Ajinomoto Co Inc | 耐糖能異常用薬剤 |
JP2005132831A (ja) * | 2003-10-06 | 2005-05-26 | Ajinomoto Co Inc | 末梢静脈投与用輸液 |
Non-Patent Citations (10)
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006061992A1 (ja) * | 2004-12-10 | 2006-06-15 | Ajinomoto Co., Inc. | 肝疾患予防・治療用組成物 |
JPWO2006061992A1 (ja) * | 2004-12-10 | 2008-06-05 | 味の素株式会社 | 肝疾患予防・治療用組成物 |
WO2007060924A1 (ja) * | 2005-11-22 | 2007-05-31 | Ajinomoto Co., Inc. | 膵β細胞保護剤 |
WO2007105730A1 (ja) * | 2006-03-13 | 2007-09-20 | Kyowa Hakko Kogyo Co., Ltd. | インスリン抵抗性改善剤 |
WO2007142297A1 (ja) * | 2006-06-09 | 2007-12-13 | Ajinomoto Co., Inc. | 肝疾患予防・治療用組成物 |
JP2010513250A (ja) * | 2006-12-15 | 2010-04-30 | ティーマ ファウンデーション | 組成物およびその使用 |
JP2014132017A (ja) * | 2006-12-15 | 2014-07-17 | Tima Foundation | 組成物およびその使用 |
US9603847B2 (en) | 2006-12-15 | 2017-03-28 | Tima Foundation | Compositions and uses thereof |
US11224582B2 (en) | 2017-04-25 | 2022-01-18 | Almeda Labs Llc | Amino acid formulations for pancreatic viability |
Also Published As
Publication number | Publication date |
---|---|
US20070071794A1 (en) | 2007-03-29 |
EP1752146A4 (en) | 2007-10-10 |
EP1752146A1 (en) | 2007-02-14 |
JPWO2005110394A1 (ja) | 2008-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005110394A1 (ja) | 糖尿病治療薬 | |
ES2487897T3 (es) | Combinaciones que consisten de inhibidores de la dipeptidilpeptidasa-IV y agentes antidiabéticos | |
ES2302702T3 (es) | Composicion farmaceutica que comprende una combinacion de metformina y glibenclamida. | |
KR101983982B1 (ko) | 2형 당뇨병 환자의 혈당 조절에 사용하기 위한 약제학적 병용물 | |
KR20090038908A (ko) | 대사 장애의 조합 치료 | |
JP6412897B2 (ja) | トリペプチド組成物および糖尿病を治療する方法 | |
TW201622720A (zh) | 藥學組成物 | |
MX2009002282A (es) | Tratamiento de combinacion para diabetes mellitius. | |
JP2008509169A (ja) | ビタミンb6関連化合物およびace阻害剤を使用する組み合わせ療法ならびに糖尿病疾患の治療のためのその使用 | |
JPWO2005049006A1 (ja) | 糖尿病治療剤 | |
TW201705974A (zh) | 第2型糖尿病病患治療 | |
JPWO2006126673A1 (ja) | 組み合わせによる糖尿病治療薬 | |
Davies | Insulin secretagogues | |
US20210401880A1 (en) | Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active Ingredient | |
WO2007060924A1 (ja) | 膵β細胞保護剤 | |
US20070259928A1 (en) | Medicinal Composition for Treating Diabetes | |
Wu et al. | Dipeptidyl peptidase IV (DPP IV): a novel emerging target for the treatment of type 2 diabetes | |
CA3001662A1 (en) | Composition for treating diabetes mellitus | |
JP4974057B2 (ja) | 血糖降下剤を含有する、耐糖能異常、境界型糖尿病、インスリン抵抗性及び高インスリン血症の改善ないし治療用医薬組成物 | |
US20150238441A1 (en) | Modulation of Branched Amino Acid Concentrations to Treat Metabolic Diseases | |
Patel et al. | TARGETED PROTEINS FOR RECENT AND EMERGING DIABETES MELLITUS RESEARCH | |
JPWO2005092363A1 (ja) | オリゴペプチドを用いた糖尿病合併症の予防・治療剤 | |
JP2011105609A (ja) | メトホルミンへの付加療法を含む2型糖尿病の治療方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006513628 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11561518 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005741366 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005741366 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11561518 Country of ref document: US |